oxiglutatione   Click here for help

GtoPdb Ligand ID: 6835

Synonyms: glutathione disulfide | Navstel®
Approved drug PDB Ligand
oxiglutatione is an approved drug (FDA (2008)-see Comment)
Compound class: Synthetic organic
Comment: The approved drug in this case is Navstel®. Oxiglutatione is listed as the active ingredient. Inhibits glutathione reductase. Note that the chemical structure given by DrugBank has opposite stereochemistry to the INN record and the ChEMBL ligand mapped here.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 18
Hydrogen bond donors 10
Rotatable bonds 25
Topological polar surface area 368.24
Molecular weight 612.15
XLogP -6.62
No. Lipinski's rules broken 3
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(NC(C(=O)NCC(=O)O)CSSCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)CCC(C(=O)O)N
Isomeric SMILES N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O
InChI InChI=1S/C20H32N6O12S2/c21-9(19(35)36)1-3-13(27)25-11(17(33)23-5-15(29)30)7-39-40-8-12(18(34)24-6-16(31)32)26-14(28)4-2-10(22)20(37)38/h9-12H,1-8,21-22H2,(H,23,33)(H,24,34)(H,25,27)(H,26,28)(H,29,30)(H,31,32)(H,35,36)(H,37,38)/t9-,10-,11-,12-/m0/s1
InChI Key YPZRWBKMTBYPTK-BJDJZHNGSA-N
No information available.
Summary of Clinical Use Click here for help
Used to treat diabetes mellitus type 2 in conjunction with diet and exercise
Mechanism Of Action and Pharmacodynamic Effects Click here for help
A sulphonylurea hypoglycemic drug which acts to stimulate insulin sectetion by pancreatic β cells